1. Home
  2. Analysis

Ipf and drugs of ingredients of bendamustine (a real world drug study)


Summary:

Ipf is reported only by a few people who take drugs with ingredients of bendamustine. This phase IV clinical study analyzes 9,503 people who have side effects while taking drugs with ingredients of bendamustine from the the FDA. Among them, 4 have Ipf. Find out below who they are, when they have Ipf and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Bendamustine.

On Jun, 27, 2026

9,503 people reported to have side effects when taking drugs with ingredients of bendamustine.
Among them, 4 people (0.04%) have Ipf

What is Ipf?

Ipf is found to be associated with 1,789 drugs and 2,276 conditions by eHealthMe. Check the latest studies of Ipf.

Number of reports submitted per year:

Could drugs with ingredients of bendamustine cause Ipf?

Time on drugs with ingredients of bendamustine when people have Ipf *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Ipf when taking drugs with ingredients of bendamustine *:

  • female: 75 %
  • male: 25 %

Age of people who have Ipf when taking drugs with ingredients of bendamustine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 0.0 %
  • 60+: 33.33 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Hodgkin's Lymphoma (cancer originating from white blood cells): 2 people, 50.00%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 25.00%
  3. Hodgkin's Disease Nodular Sclerosis Stage Iv (cancer originating from white blood cells- stage iv): 1 person, 25.00%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Adcetris: 2 people, 50.00%
  2. Xeljanz: 1 person, 25.00%
  3. Cimzia: 1 person, 25.00%
  4. Ergocalciferol: 1 person, 25.00%
  5. Erelzi: 1 person, 25.00%
  6. Enbrel: 1 person, 25.00%
  7. Dexamethasone: 1 person, 25.00%
  8. Cyclosporine: 1 person, 25.00%
  9. Cyanocobalamin: 1 person, 25.00%
  10. Codeine: 1 person, 25.00%

Other side effects people have besides Ipf *:

You may use this to check any potential undetected side effects.

  1. Pneumonia: 2 people, 50.00%
  2. Thrombocytopenia (decrease of platelets in blood): 1 person, 25.00%
  3. C-Reactive Protein Increased: 1 person, 25.00%
  4. Granuloma Skin (a small area of inflammation on skin due to tissue injury): 1 person, 25.00%
  5. Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 1 person, 25.00%
  6. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 25.00%
  7. Gastric Ulcer (stomach ulcer): 1 person, 25.00%
  8. Febrile Neutropenia (fever with reduced white blood cells): 1 person, 25.00%
  9. Drug Tolerance Decreased: 1 person, 25.00%
  10. Drug Intolerance (drug sensitivity): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of bendamustine, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on bendamustine. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.